N-Acetyl Cysteine in treatment of COPD

Journal Title: IP Indian Journal of Immunology and Respiratory Medicine - Year 2018, Vol 3, Issue 3

Abstract

Introduction In COPD excess expectoration secondary to tracheobronchial secretions contributes to symptoms airflow obstruction and is diagnostic criterion It also causes increased mortality risk of hospitalizations and accelerated decline in FEV1 Nacetylcysteine NAC helps in liquefying mucus and DNA via disruption of disulfide bonds and has antioxidant effectsAims Evaluate addon effect of NAC on clinicalphysiological parameters in COPD patients treated according to GOLD guidelinesMaterial and Methods Single labeled randomized parallel group prospective Observational study In 120 stable COPD patients Modified medical research council MMRC dyspnoea score COPD Assessment test CAT score number of exacerbations and hospitalizations in the last year were recorded and were randomized into 2 groups of 60 each Group A received NAC 600mg twice daily along with standard treatment Group B received standard treatment only Mean and Standard Deviation was compared between groups using unpaired ttest After 1 year changes in above parameters were reassessedStatistical Analysis Unpaired ttest and chi square test were used Statistical significance was set at Results MMRC score reduced from 337 study group to 291 difference being 046 and in control from 337 to 118 difference of 022 and p value of p

Authors and Affiliations

Aleemuddin MM, Raheem Fatima, Mohsin Dr, Ashfaq Hasan

Keywords

Related Articles

Changing trends in histopathology of lung cancer in a tobacco prevalent area of South India

Background Lung cancer is the most devastating disease of mankind among all cancers in the world with 18 million cases In the west adenocarcinoma of lung is the most common type accounts for 385 followed by squamous 23 a...

Nipah Virus (NiV) Infection- A new outbreak in India

The recent reports of Nipah virus NiV infection resulting in a number of deaths have created panic and fear among the general public The resource poor overpopulated countries like Bangladesh India and Malaysia are hit by...

N-Acetyl Cysteine in treatment of COPD

Introduction In COPD excess expectoration secondary to tracheobronchial secretions contributes to symptoms airflow obstruction and is diagnostic criterion It also causes increased mortality risk of hospitalizations and a...

Changing trends in aetiology and antibiotic resistance of symptomatic community acquired bacterial pneumonia in hospitalised adult patients -A South Indian study

Background Community Acquired Pneumonia CAP of bacterial origin in adults is a leading cause of mortality and morbidity in developing countries Etiological diagnosis plays a significant role in hospitalised patients for...

Tracheo-bronchial diverticulosis and bronchiectasis

A 65-year-old male patient, ex-smoker, presented to pulmonary medicine OPD with complaints of cough with expectoration for 15 days. Patient was having similar complaints for past 10 years and was treated as a case of lef...

Download PDF file
  • EP ID EP490608
  • DOI 10.18231/2581-4222.2018.0035
  • Views 79
  • Downloads 0

How To Cite

Aleemuddin MM, Raheem Fatima, Mohsin Dr, Ashfaq Hasan (2018). N-Acetyl Cysteine in treatment of COPD. IP Indian Journal of Immunology and Respiratory Medicine, 3(3), 137-146. https://europub.co.uk/articles/-A-490608